The 30-second summary
- The medicine and the fast do the same thing, which is the core problem: both shrink the window and the appetite available for food, while your protein requirement stays exactly where it was.
- Real-world data is reassuring and limited. In 109 adults with type 2 diabetes on tirzepatide through Ramadan, HbA1c fell from 7.6% to 6.5%, weight fell 5.3 kg, and no hypoglycaemia was reported.
- Dehydration is the risk to plan for, not hunger. Vomiting or diarrhoea during a daylight fast cannot be corrected until sunset.
- The most common harm is not the fast, it is the restart. Going back to a maintenance dose after a pause is a known route to a genuinely bad week.
Why this combination is harder than either alone
Ramadan compresses eating into the hours between sunset and dawn. In northern latitudes in summer that can mean a fast of sixteen hours or more, and two meals to carry a whole day.
Two meals is enough for most people. It is much less clearly enough for someone whose appetite has been reduced by a third, who fills after a few mouthfuls, and who needs 100 g or more of protein a day to protect muscle while losing weight. The fast does not lower the protein requirement. It narrows the door it has to fit through.
There is a second squeeze. A medicine that slows the stomach means a meal eaten at iftar is still being processed hours later, which reduces how much room suhoor has. People frequently report that the pre-dawn meal, the one that has to carry the entire day, is the one they can least face.
What the studies found
The evidence is mostly in people with type 2 diabetes, because that is where the clinical concern about fasting has always been.
A prospective, multicentre, real-world study followed 109 adults with type 2 diabetes in Bangladesh who intended to fast and were prescribed tirzepatide 2.5 mg weekly, alone or alongside other medicines, with measurements taken two to six weeks before Ramadan and two to six weeks after. Mean HbA1c fell from 7.6% to 6.5%, a change of 1.1 percentage points. Fasting plasma glucose fell by 2 mmol/L and two-hour post-meal glucose by 3.8 mmol/L. Mean weight fell by 5.3 kg, 6.3% of baseline. Mild gastrointestinal events occurred in about 12% of participants, and no hypoglycaemia was reported.
The absence of hypoglycaemia is the useful finding, and it is consistent with the pharmacology: GLP-1s stimulate insulin in a glucose-dependent way, so they do not drive blood sugar down when there is no glucose to act on. That is a meaningful difference from insulin or a sulfonylurea, which do not care whether you have eaten.
Read it with proper caution. It is one observational study, in people with diabetes, at a low tirzepatide dose, in one country with one daylight length. It is not a licence, and it says nothing about someone on 15 mg in a northern summer.
The restart problem
This is the part most worth carrying away, because it is where people actually come to harm, and it happens after Ramadan rather than during it.
Tolerance to these medicines is built, not permanent. The four to eight weeks of dose escalation exist because the gut needs that long to adapt. When doses are missed for several weeks, that adaptation fades, and a dose that was comfortable in February can be overwhelming in April.
A published case report describes severe gastrointestinal intolerance after resuming a maintenance dose of semaglutide following a Ramadan-related interruption. One case is not an incidence rate. It is a clear illustration of a mechanism that is well understood.
If you pause, agree the restart plan before you pause. The usual approach is to step back down and titrate up again, and that conversation takes two minutes if you have it in advance and a fortnight of misery if you do not.
Building suhoor and iftar around a small appetite
Suhoor is a protein meal, not a carbohydrate meal. It has to hold you for sixteen hours and protect muscle across them. Eggs, labneh or Greek yoghurt, cheese, ful medames, a lentil soup, or milk on oats. Put the protein in first, while you have the most appetite and the least time pressure.
Drink at suhoor deliberately. Not one large glass at the end, which mostly leaves again. Fluid spread across the meal, and salt with the food, because sodium helps you hold what you drink. Avoid making the last thing you drink a strong coffee.
Break the fast in two stages. Dates and water, then the prayer, then the meal. This is the traditional order and it happens to be exactly right for a slowed stomach: a small amount of sugar and fluid, a pause of fifteen or twenty minutes, then food arriving at a stomach that has woken up. Going straight to a full plate after sixteen hours is how people end up unable to eat anything more that evening.
At iftar, protein before bread and rice. If you fill after a third of the plate, the third you ate should be the meat, fish, chicken, lentils or beans. Everything else is optional in a way protein is not.
Add a third small meal before bed if you can. Not a full meal. Yoghurt, a glass of milk, a handful of nuts. On a small appetite, three small occasions carry far more than two attempted large ones.
Keep fibre and fluid together. Constipation is already the most common complaint on these medicines, and a long daylight fast makes it worse. Dates, figs, lentils, wholemeal bread and a genuine effort at fluid across the night hours.
When to stop fasting
Most rulings exempt the sick, and the following are illness rather than discomfort.
Persistent vomiting or diarrhoea, because you cannot replace fluid until sunset and dehydration builds quietly. Dizziness on standing, or a racing pulse. Severe, persistent abdominal pain that spreads to your back, which needs urgent medical attention on this medicine regardless of the day. And symptoms of low blood sugar if you take insulin or a sulfonylurea alongside your GLP-1.
Breaking a fast for these reasons is not a failure of discipline. It is the rule working as intended.
What to do with this
Two meals have to carry a full day's protein, and the first step is knowing what that number is. The calculator sets it from your weight and your dose, and can build a plan around your cuisine.
Sources
- Real-world evidence on safety and effectiveness of tirzepatide during Ramadan fasting in patients with type 2 diabetes. Diabetes Obes Metab 2026. PubMed
- Severe Gastrointestinal Intolerance After Resuming Maintenance-Dose Semaglutide Following a Ramadan-Related Interruption. Cureus 2026. PubMed
- Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes during Ramadan. World J Methodol 2025. PubMed
- MHRA. GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, 29 January 2026. GOV.UK
Medical disclaimer: Articles in the foodose research library are educational, not medical advice. Follow the instructions from your prescriber and the leaflet in your pack. See our full medical disclaimer.